Aristo Bio-tech An
NSE: ARISTO-SM
NSE
132.70
0.00 (0.00%)
Prev Close
132.7
Open Price
120.25
Volume
4,800
Today Low / High
120.25 / 132.7
52 WK Low / High
120.25 / 132.7
Range
126 - 139
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 132.7, with a change of 0 (0%). The expected target range on the NSE is between 126 - 139. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
30 Sep
120.25
10.35%
29 Sep
126.20
0.00%
22 Sep
137.80
0.00%
19 Sep
137.80
0.00%
18 Sep
134.00
2.99%
16 Sep
129.30
7.50%
15 Sep
136.00
2.94%
12 Sep
136.00
0.00%
10 Sep
130.00
0.00%
08 Sep
129.95
0.04%
Aristo Bio-tech An Graph
Aristo Bio-tech An Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aristo Bio-tech An T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 132.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 132.70 | 134.03 | 120.62 - 147.43 |
| 135.35 | 108.28 - 162.42 | ||
| 136.68 | 95.68 - 177.69 | ||
| Bearish Scenario | 132.70 | 131.37 | 118.24 - 144.51 |
| 130.05 | 104.04 - 156.06 | ||
| 128.72 | 90.10 - 167.33 |
Overview of Aristo Bio-tech An
ISIN
Industry
Chemicals
Vol.Avg
14,011
Market Cap
0
Last Dividend
0
Official Website
IPO Date
2023-01-01
DCF Diff
186.85
DCF
-54
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 318.09 Cr | 295.85 Cr | 22.24 Cr | 0.0699 | 0.00 Cr | 4.13 Cr | 18.10 Cr | 4.06 Cr | 5.97 | 9.48 Cr | 0.0128 |
| 2024-03-31 | 245.15 Cr | 226.04 Cr | 19.11 Cr | 0.0780 | 0.00 Cr | 3.70 Cr | 15.38 Cr | 3.90 Cr | 5.72 | 8.56 Cr | 0.0159 |
| 2023-03-31 | 217.86 Cr | 196.00 Cr | 21.86 Cr | 0.1003 | 0.00 Cr | 5.82 Cr | 16.01 Cr | 3.56 Cr | 6.72 | 8.79 Cr | 0.0164 |
| 2022-03-31 | 165.76 Cr | 147.20 Cr | 18.56 Cr | 0.1120 | 0.00 Cr | 5.39 Cr | 13.17 Cr | 1.43 Cr | 2.87 | 5.23 Cr | 0.0086 |
| 2021-03-31 | 167.22 Cr | 150.15 Cr | 17.07 Cr | 0.1021 | 0.00 Cr | 3.63 Cr | 13.44 Cr | 1.08 Cr | 2.15 | 4.34 Cr | 0.0064 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.30 Cr | 140.62 Cr | 103.29 Cr | 37.3313 Cr | 21.85 Cr | 17.56 Cr | 47.37 Cr | 23.95 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 95.5758 Cr |
| 2024-03-31 | 5.41 Cr | 127.29 Cr | 93.68 Cr | 33.6086 Cr | 20.88 Cr | 15.46 Cr | 40.19 Cr | 21.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 83.5682 Cr |
| 2023-03-31 | 3.80 Cr | 99.83 Cr | 69.67 Cr | 30.1554 Cr | 22.49 Cr | 18.69 Cr | 30.78 Cr | 16.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 59.4856 Cr |
| 2022-03-31 | 2.60 Cr | 77.00 Cr | 62.14 Cr | 14.8657 Cr | 25.48 Cr | 22.88 Cr | 24.36 Cr | 14.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 50.9393 Cr |
| 2021-03-31 | 0.11 Cr | 81.42 Cr | 68.04 Cr | 13.3808 Cr | 22.25 Cr | 22.14 Cr | 31.95 Cr | 12.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 55.9727 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 10.0167 Cr | -5.1468 Cr | -4.3914 Cr | 4.9102 Cr | 0.4784 Cr | 1.1155 Cr | -5.1065 Cr | 4.0631 Cr | -2.3564 Cr | -0.3404 Cr | -7.1791 Cr |
| 2024-03-31 | 7.6004 Cr | -6.6096 Cr | -2.2066 Cr | 1.0455 Cr | -1.2158 Cr | 0.6371 Cr | -6.5549 Cr | 3.8957 Cr | -0.1696 Cr | -0.4425 Cr | -9.4095 Cr |
| 2023-03-31 | -2.7836 Cr | -3.7456 Cr | 7.9657 Cr | -6.8441 Cr | 1.4365 Cr | 1.8529 Cr | -4.0605 Cr | 3.5622 Cr | -0.9251 Cr | 0.0000 Cr | -6.4152 Cr |
| 2022-03-31 | 6.7781 Cr | -3.1601 Cr | -3.3138 Cr | 3.5293 Cr | 0.3041 Cr | 0.4164 Cr | -3.2488 Cr | 1.4338 Cr | -0.9689 Cr | 0.0000 Cr | 7.5833 Cr |
| 2021-03-31 | 2.2841 Cr | -1.9778 Cr | -0.7191 Cr | 0.2948 Cr | -0.4128 Cr | 0.1123 Cr | -1.9893 Cr | 1.0757 Cr | 1.3891 Cr | 0.0000 Cr | -7.6214 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 51.97 Cr | 49.24 Cr | 2.73 Cr | 0.0525 | 1.62 Cr | -0.25 Cr | -0.36 | 0.67 Cr | -0.0047 |
| 2024-12-31 | 51.97 Cr | 49.24 Cr | 2.73 Cr | 0.0525 | 1.62 Cr | -0.25 Cr | -0.36 | 0.67 Cr | -0.0047 |
| 2024-09-30 | 107.07 Cr | 98.68 Cr | 8.39 Cr | 0.0784 | 7.43 Cr | 2.28 Cr | 3.35 | 4.07 Cr | 0.0213 |
| 2024-06-30 | 107.07 Cr | 98.68 Cr | 8.39 Cr | 0.0784 | 7.43 Cr | 2.28 Cr | 3.35 | 4.07 Cr | 0.0213 |
| 2024-03-31 | 56.16 Cr | 52.07 Cr | 4.09 Cr | 0.0728 | 4.01 Cr | 0.66 Cr | 0.97 | 1.66 Cr | 0.0118 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.30 Cr | 0.00 Cr | 4.30 Cr | 56.18 Cr | 47.37 Cr | 115.76 Cr | 23.95 Cr | 140.62 Cr | 103.29 Cr |
| 2024-12-31 | 4.30 Cr | 0.00 Cr | 4.30 Cr | 56.18 Cr | 47.37 Cr | 115.76 Cr | 23.95 Cr | 140.62 Cr | 103.29 Cr |
| 2024-09-30 | 0.78 Cr | 0.00 Cr | 0.78 Cr | 142.27 Cr | 44.71 Cr | 199.45 Cr | 23.18 Cr | 223.28 Cr | 185.12 Cr |
| 2024-06-30 | 0.78 Cr | 0.00 Cr | 0.78 Cr | 142.27 Cr | 44.71 Cr | 199.45 Cr | 23.18 Cr | 223.28 Cr | 185.12 Cr |
| 2024-03-31 | 5.41 Cr | 0.00 Cr | 5.41 Cr | 57.47 Cr | 40.19 Cr | 105.03 Cr | 21.68 Cr | 127.29 Cr | 93.68 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.25 Cr | 2.42 Cr | -1.19 Cr | -1.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1.05 Cr | 1.38 Cr |
| 2024-12-31 | -0.25 Cr | 2.42 Cr | -1.19 Cr | -1.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1.05 Cr | 1.38 Cr |
| 2024-09-30 | 2.28 Cr | 2.59 Cr | -1.38 Cr | -1.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1.51 Cr | 1.08 Cr |
| 2024-06-30 | 2.28 Cr | 2.59 Cr | -1.38 Cr | -1.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1.51 Cr | 1.08 Cr |
| 2024-03-31 | 0.66 Cr | 2.26 Cr | -2.03 Cr | -0.28 Cr | -0.05 Cr | -0.05 Cr | 0.00 Cr | -1.98 Cr | 0.28 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Chemicals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Gujarat Fluorochemicals Limited | FLUOROCHEM | ₹3,710.50 | ₹407,598,425,000.00 | ₹59,852.00 |
| Deepak Nitrite Limited | DEEPAKNTR | ₹1,843.00 | ₹251,372,374,563.00 | ₹58,345.00 |
| Navin Fluorine International Limited | NAVINFLUOR | ₹4,610.00 | ₹236,136,020,040.00 | ₹33,040.00 |
| Tata Chemicals Limited | TATACHEM | ₹918.45 | ₹233,980,903,529.00 | ₹552,179.00 |
| Deepak Fertilisers And Petrochemicals Corporation Limited | DEEPAKFERT | ₹1,548.60 | ₹195,491,895,795.00 | ₹271,278.00 |
| Supreme Petrochem Limited | SPLPETRO | ₹820.40 | ₹154,268,678,883.00 | ₹294,089.00 |
| Archean Chemical Industries Limited | ACI | ₹690.35 | ₹85,208,300,269.00 | ₹87,202.00 |
| Epigral Limited | EPIGRAL | ₹1,731.00 | ₹74,677,656,078.00 | ₹15,746.00 |
| Gujarat Narmada Valley Fertilizers & Chemicals Limited | GNFC | ₹496.70 | ₹72,985,437,246.00 | ₹180,750.00 |
| Chemplast Sanmar Limited | CHEMPLASTS | ₹387.00 | ₹61,188,405,138.00 | ₹35,420.00 |
| GHCL Limited | GHCL | ₹608.00 | ₹58,411,828,288.00 | ₹94,309.00 |
| India Glycols Limited | INDIAGLYCO | ₹864.95 | ₹53,560,298,850.00 | ₹156,113.00 |
| Meghmani Finechem Limited | MFL | ₹1,062.00 | ₹44,126,312,400.00 | ₹146,962.00 |
| Rain Industries Limited | RAIN | ₹130.39 | ₹43,856,113,085.00 | ₹771,083.00 |
| Gujarat Alkalies and Chemicals Limited | GUJALKALI | ₹556.00 | ₹40,830,931,968.00 | ₹23,158.00 |
| Meghmani Organics Limited | MEGH | ₹139.00 | ₹35,285,704,610.00 | ₹5,511,910.00 |
| Foseco India Limited | FOSECOIND | ₹5,514.00 | ₹35,214,934,926.00 | ₹7,492.00 |
Key Executives
No executive data available.
FAQs about Aristo Bio-tech An
What is the current market price of the stock?
The current price is ₹132.70.
What is the 52-week price range?
The range is ₹120.25-132.7.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 22.24.
Which sector does the company belong to?
The company operates in the Basic Materials sector.
What does the company do?
Overview of Aristo Bio-tech An (ISIN: ) is a leading Chemicals in India. With a market capitalization of ₹0.00 crores and an average daily volume of 14,011 shares, it operates in the Chemicals. The company last declared a dividend of ₹0.